
UnitedHealth unit to add eight insulin products to its reimbursement list
(Reuters) -UnitedHealth's pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that
2023-11-10 01:29

US senators push drugmakers for details on low-cost insulin programs
By Patrick Wingrove (Reuters) -Two U.S. senators are demanding that the nation's three largest insulin makers, Novo Nordisk, Eli Lilly,
2023-09-01 00:25

Uninsured US patients pay up to $330 for Eli Lilly’s $25 insulin, Senator Warren says
By Patrick Wingrove Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite
2023-07-13 19:17

Pharma CEOs to testify in U.S. Senate hearing on insulin prices
By Ahmed Aboulenein WASHINGTON The leaders of major insulin makers and pharmacy benefit managers (PBMs) are set to
2023-05-10 19:25